Moderna, Novavax to produce more Covid-19 vaccines in South Korea
Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. Photo: Reuters/Dado Ruvic/Illustration
Reuters
Reuters
Moderna Inc (MRNA.O) and Novavax Inc (NVAX.O) entered into a deal with the South Korean government to manufacture their COVID-19 vaccines, as the country has been under pressure to secure more and faster deliveries of US-made vaccines.
Saturday s agreements with the US drugmakers came a day after US President Joe Biden said that he and South Korean President Moon Jae-in had agreed on a comprehensive partnership on COVID-19 vaccines and that the United States would provide vaccinations for 550,000 South Korean soldiers.
Moderna, Novavax to produce more COVID-19 vaccines in South Korea msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Posted : 2021-04-29 09:17 By Lee Hyo-jin
Lee Pil-soo, vice president of the Korea Medical Association (KMA), the largest doctors group in the country, has been elected as the new president of the association.
His three-year term as the 41st president will begin on May 1, replacing incumbent head Choi Dae-zip.
Lee Pil-soo, 41st president of the Korea Medical Association / Courtesy of Korea Medical AssociationLee won the runoff vote which took place at the association s headquarters in Yongsan District, Seoul, on March 26, by garnering 12,431 votes, or 52 percent of the 23,658 valid votes. In this particular period that we are in, I feel a strong sense of responsibility as the new president. My mission is to lead the association in playing a pivotal role in overcoming the coronavirus pandemic, and at the same time, I will put all my efforts into protecting the rights of our 130,000 members, he said during a speech at a KMA meeting, Sunday.
31 January 2021 15:31 Share in:
SEOUL. KAZINFORM South Korea decided Sunday to extend tougher social distancing measures for another two weeks, as it is wary of a pileup in cluster infections ahead of the Lunar New Year holiday. Related news The country will maintain the Level 2.5 measures, the second-highest in its five-tier scheme, in the greater Seoul area and Level 2 in other regions until Feb. 14, according to health authorities, Yonhap reports. It will also continue to ban private gatherings of five or more people in an effort to rein in the spread of the new coronavirus ahead of the holiday, set for Feb. 11-14.